The abstract is read at the publisher; the summary is JClub's.
Ubiquitous AAV8-driven mouse GHR expression in female GHR-deficient Laron dwarf mice improved body size by nearly 25–30% and skeletal growth by over 8% more than liver-specific expression.
- Why it matters: Laron syndrome involves severe postnatal growth failure from loss of GHR function, and prior liver-targeted gene delivery only partially restored growth, leaving room for more effective systemic approaches.
- What they did: Laron dwarf mice received a four-fold higher AAV8 dose expressing mouse GHR under either a liver-specific promoter (AAV8-HLP-mGHR) or a ubiquitous promoter (AAV8-CAG-mGHR), with hepatic Igf1 transcription and serum IGF1 assessed.
- The result: Both promoter strategies increased hepatic Igf1 transcription and serum IGF1 while decreasing serum growth hormone, but ubiquitous GHR expression produced the larger growth gains, supporting systemic GHR restoration development.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.